Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis.
Nazzani S, Catanzaro M, Biasoni D, Maccauro M, Stagni S, Torelli T, Macchi A, Bernasconi V, Taverna A, Sessa D, Lorenzoni A, Piva L, Lanocita R, Cascella T, Cattaneo L, Montanari E, Salvioni R, Nicolai N. Nazzani S, et al. Among authors: piva l. Urol Oncol. 2023 Apr;41(4):210.e1-210.e8. doi: 10.1016/j.urolonc.2023.02.001. Epub 2023 Mar 1. Urol Oncol. 2023. PMID: 36868883
Penile cancer.
Salvioni R, Necchi A, Piva L, Colecchia M, Nicolai N. Salvioni R, et al. Among authors: piva l. Urol Oncol. 2009 Nov-Dec;27(6):677-85. doi: 10.1016/j.urolonc.2009.07.017. Urol Oncol. 2009. PMID: 19879479
Clinical Outcomes in Clinical N0 Squamous Cell Carcinoma of the Penis According to Nodal Management: Early, Delayed or Selective (following Dynamic Sentinel Node Biopsy) Inguinal Lymph-Node Dissection.
Nazzani S, Catanzaro M, Biasoni D, Maccauro M, Zaborra C, Stagni S, Torelli T, Macchi A, Tesone A, Lorenzoni A, Piva L, Lanocita R, Colecchia M, Montanari E, Salvioni R, Pizzocaro G, Nicolai N. Nazzani S, et al. Among authors: piva l. J Urol. 2021 Aug;206(2):354-363. doi: 10.1097/JU.0000000000001775. Epub 2021 Apr 12. J Urol. 2021. PMID: 33843260
Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence.
Nicolai N, Miceli R, Necchi A, Biasoni D, Catanzaro M, Milani A, Piva L, Pizzocaro G, Stagni S, Torelli T, Salvioni R. Nicolai N, et al. Among authors: piva l. Eur Urol. 2010 Dec;58(6):912-8. doi: 10.1016/j.eururo.2010.08.032. Epub 2010 Aug 27. Eur Urol. 2010. PMID: 20817343
Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.
Nicolai N, Colecchia M, Biasoni D, Catanzaro M, Stagni S, Torelli T, Necchi A, Piva L, Milani A, Salvioni R. Nicolai N, et al. Among authors: piva l. J Urol. 2011 Oct;186(4):1298-302. doi: 10.1016/j.juro.2011.05.070. Epub 2011 Aug 17. J Urol. 2011. PMID: 21849196
Combination of paclitaxel, cisplatin, and gemcitabine (TPG) for multiple relapses or platinum-resistant germ cell tumors: long-term outcomes.
Necchi A, Nicolai N, Mariani L, Lo Vullo S, Giannatempo P, Raggi D, Farè E, Piva L, Biasoni D, Catanzaro M, Torelli T, Stagni S, Milani A, Gianni AM, Salvioni R. Necchi A, et al. Among authors: piva l. Clin Genitourin Cancer. 2014 Feb;12(1):63-69.e1. doi: 10.1016/j.clgc.2013.07.005. Epub 2013 Oct 23. Clin Genitourin Cancer. 2014. PMID: 24161525 Clinical Trial.
165 results